by Steve Schonberg | Oct 5, 2020 | Hear From the Scientists
Genomics is a field of biology that focuses on the structure, function, evolution, mapping and editing of genomes—an organism’s complete set of DNA, including all of its genes. As research into ALS continues to advance, genomics is playing an essential role in...
by Steve Schonberg | Dec 18, 2019 | Hear From the Scientists
Recently, researchers at the University of Florida, biotechnology companies Biogen and Neurimmune, and collaborators at Johns Hopkins University published preclinical research that shows promise toward a potential treatment for Amyotrophic Lateral Sclerosis (ALS)....
by Steve Schonberg | Nov 26, 2019 | Hear From the Scientists
Recently, researchers identified unique pathways which contribute to the development of Amyotrophic Lateral Sclerosis (ALS). Led by researchers from Cold Spring Harbor Laboratory and the New York Genomic Center ALS Consortium, this research advances our current...
by Target ALS | Oct 19, 2018 | Hear From the Scientists
The ALS drug KPT-350 was one of the first of a dozen therapeutic options to emerge from the Target ALS Innovation Ecosystem and is now poised for clinical trial thanks to the power of collaboration. Shortly after its launch, Target ALS forged and funded one of the...
